Bli medlem
Bli medlem

Du är här

2016-11-08

Dignitana AB: DIGNITANA AB NAMES TOP TECH ENGINEER JOHAN ERICSSON AS CHIEF EXECUTIVE OFFICER AND EXPANDS U.S. LEADERSHIP TEAM

William Cronin to Serve as Chief Executive Officer of Dignitana Inc.
in the United States

Dallas-Based Dignitana Inc. Adds James McKinney as COO, Melissa
Bourestom as VP Marketing,

and Registered Nurse Josephine Divers as VP Clinical Oncology Services
Lund, Sweden and Dallas, TX - November 8, 2016-Nearing the one-year
anniversary of FDA clearance for its DigniCap® system, Dignitana AB,
a world leader in medical scalp cooling technology, announced today
the appointments of Johan Ericsson as Chief Executive Officer and
William Cronin as Chief Executive Officer of Dignitana, Inc. in
United States.

After shepherding the DigniCap® system through its inaugural year of
growth in the United States, current CEO Jan Richardsson will now
hand over the reins to a development and operational CEO.

Johan Ericsson brings more than 25 years of global engineering and
product development experience to Dignitana, holding leadership
positions at Flex Design (formerly Flextronics), Sony Ericsson, Assa
Abloy, CellaVision, and Axis Communications. He has initiated,
implemented, and launched product platforms across a variety of
health and technology sectors, including radar and infrared systems,
mechanics, electronics, optics and software/firmware. Ericsson's
experience also includes guiding products through FDA approval and
clearance and introducing supply chain and scalability innovations in
addition to developing quality competence measures at all points
along the product development continuum.

"Under Jan Richardsson's leadership, we have built relationships in
the U.S. and around the world, that have allowed Dignitana to
successfully enter the U.S. market and quickly expand following FDA
clearance of the DigniCap® system. We thank him for his invaluable
contributions to the company. As Johan takes the helm, emphasis will
shift slightly to technological refinements aimed at ensuring an even
more precise and effective patient experience that can be used with
more treatments and drug combinations." says Semmy Rülf, chairman of
the board at Dignitana AB.

"I see this appointment as a great opportunity to bring my experience
to a successful company and to move it to the next level of product
development and operations. Together with the strong U.S.
organization I am confident that we will grow both the business and
the company." says Johan Ericsson.

Newly appointed CEO of Dignitana's American operations, Bill Cronin,
led the business through the final stages of FDA clearance in
December of 2015 and brought the DigniCap® scalp cooling system to
more than 35 medical centers across 16 U.S. states in its first year
of production.

"We are excited to expand the number of treatment centers across the
US that are making the DigniCap® system available to their patients.
Dignitana now has the proper infrastructure in place, both in the US
and in Sweden, to fully execute on our plan of making this valuable
therapy option available to as many patients across the US as
possible," says William Cronin.

As leadership in Sweden focuses on advancing the next phase of
innovation, design and production of the medical device, patient
experience measures will be top priority in the United States. James
McKinney has stepped in as Chief Operating Officer, Melissa Bourestom
has taken on the role of Vice President of Marketing and Josephine
Divers, R.N., rounds out the U.S. executive team as Vice President of
Clinical Oncology Services for Dignitana Inc in Dallas. These new
hires will allow the company to build brand recognition, and support
patients and clinical staff as the device expands to more medical
centers nationwide.

As COO of Dignitana, Inc., James McKinney brings extensive experience
and a proven track record in leadership and operations including
physician relations and partnership, program design and
implementation, financial performance and system integration. Recent
leadership roles include Division CEO of Anesthesia for EmCare,
Division President of Iasis, President and COO of Leland Medical, and
President and CEO of Brim Healthcare. He also serves as a healthcare
consultant to Catholic Charities.

Prior to joining Dignitana as Vice President of Marketing, Melissa
Bourestom led strategic partnership efforts as Executive Director of
the American Advertising Federation Dallas and previously directed
marketing and sales initiatives for myFootpath, an education
technology start-up focused on integrating product usage with
e-business objectives. She brings to the Dignitana team a passion for
science and healthcare and more than 20 years' experience in
marketing, communications, event planning and sales with expertise in
achieving sales and marketing objectives and building strong customer
relationships via traditional marketing, social media and digital
strategies.

As the newly appointed Vice President of Clinical Oncology Services,
Josephine Divers brings extensive clinical oncology nursing
experience to j the Dignitana team with experience. She is a licensed
registered nurse with 25 years' experience in professional and
collaborative patient care. Divers spent 20 years dedicated to
oncology nursing with a specialization in breast cancer for the past
15 years. Prior to joining Dignitana, Divers served as a Registered
Clinical Oncology Nurse for seven years at Baylor/Sammons Cancer
Center, an institution of U.S Oncology. Divers possesses the
educational background, clinical experience, and genuine enthusiasm
for effective and efficient breast cancer treatment as part of a
larger, interdisciplinary health care team. Her research and clinical
trial experience includes published literature in Cancer Medicine,
Journal of Oncology Nursing, as well as various findings presented at
National Oncology Nursing Conference.

"As awareness and demand for the product continue to grow, we are
thrilled to be able to add these talented and experienced healthcare
professionals to our team. Our commitment to support our patients and
partner treatment sites has made the addition of a specialized
leadership team essential. We are excited to introduce expanded
distribution and training channels led by James McKinney, targeted
marketing efforts headed up by Melissa Bourestom, and clinical
experience in breast oncology led by Josie Divers," says William
Cronin.

"Providing personalized clinical expertise and guidance for patients
throughout their breast cancer experience is an unwavering commitment
for the Dignitana leadership team," Cronin adds. "We are thrilled to
have Jim, Melissa and Josie on board, and look forward to expanding
operations, brand awareness and patient support in the coming year. I
am confident that our shared passion and expertise will strengthen
our patient-centered mission."

Media Contacts:

USA Sweden

Caren Browning Semmy Rülf

King + Company Chairman of the board, Dignitana AB

00 1 212 561-7464 0046 (0)709 312730

Caren.Browning@kingcompr.com semmy.rulf@gmail.com

###

The information in this press release is such that Dignitana AB must
disclose it in accordance with the EU market abuse regulation. The
information was submitted, by the above contact, for publication at
9.00 (CET), November 8, 2016.

About Dignitana
Dignitana AB is a Swedish public company, based in Lund, and
manufacturer of the medical cooling device DigniCap®. Dignitana AB is
listed on the OMX Nasdaq First North stock exchange and has appointed
Erik Penser Bank as Certified Advisor. Headquartered in Dallas,
Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. For
more information visit www.dignitana.com.

About the scalp cooling system DigniCap®
Dignitana's core product - DigniCap® - is a patented scalp-cooling
system that offers cancer patients the ability to keep their hair
during chemotherapy. DigniCap® is developed to provide continuous
cooling with high efficacy, safety and acceptable patient comfort.

-----------------------------------------------------------
http://news.cision.com/se/dignitana-ab/r/dignitana-ab-names-top-tech-eng...
http://mb.cision.com/Main/2116/2117818/586526.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.